Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients

被引:0
作者
Salvatore Paiella
Giuseppe Malleo
Ivana Cataldo
Clizia Gasparini
Matteo De Pastena
Giulia De Marchi
Giovanni Marchegiani
Borislav Rusev
Aldo Scarpa
Roberto Girelli
Alessandro Giardino
Isabella Frigerio
Mirko D’Onofrio
Erica Secchettin
Claudio Bassi
Roberto Salvia
机构
[1] University of Verona Hospital Trust,General and Pancreatic Surgery Department, Pancreas Institute
[2] University of Verona Hospital Trust,Department of Pathology and Diagnostics
[3] University of Verona Hospital Trust,Gastroenterology B Department, Pancreas Institute
[4] University of Verona Hospital Trust,ARC
[5] HPB Unit,Net Research Centre
[6] Casa di Cura Pederzoli,Department of Radiology, Pancreas Institute
[7] University of Verona Hospital Trust,undefined
来源
Langenbeck's Archives of Surgery | 2018年 / 403卷
关键词
Pancreatic cancer; Radiofrequency ablation; SMAD4; Locally advanced pancreatic cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:213 / 220
页数:7
相关论文
共 387 条
[1]  
Siegel RL(2015)Cancer statistics, 2015 CA Cancer J Clin 65 5-29
[2]  
Miller KD(2009)SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer Clin Cancer Res 15 4674-4679
[3]  
Jemal A(2014)The management of locally advanced pancreatic cancer: European Society of Digestive Oncology (ESDO) expert discussion and recommendations from the 14th ESMO/ World Congress on Gastrointestinal Cancer, Barcelona Ann Oncol 25 ii1-ii4
[4]  
Blackford A(2011)Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis Ann Surg 254 882-893
[5]  
Serrano OK(2016)Meta-analysis of benefits of portal-superior mesenteric vein resection in pancreatic resection for ductal adenocarcinoma Br J Surg 103 179-191
[6]  
Wolfgang CL(2016)Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: the LAP07 Randomized Clinical Trial JAMA 315 1844-1853
[7]  
Parmigiani G(2012)Combined modality treatment for patients with locally advanced pancreatic adenocarcinoma Br J Surg 99 1083-1088
[8]  
Jones S(2016)Local ablative strategies for ductal pancreatic cancer (radiofrequency ablation, irreversible electroporation): a review Gastroenterol Res Pract 2016 4508376-1813
[9]  
Zhang X(2009)DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer J Clin Oncol 27 1806-1094
[10]  
Parsons DW(2012)Genetic evolution of pancreatic cancer: lessons learnt from the pancreatic cancer genome sequencing project Gut 61 1085-1117